Inventor · disambiguated record
Taro Semba
Also filed as: SEMBA TARO
9 granted patents·14 pending applications·108 citations·filing 1999–2022
86Inventor score
Files withEISAI R&D MAN CO LTD11EISAI CO LTD5WAKABAYASHI TOSHIAKI2ESAI R & D MAN CO LTD1MERCIAN CORP AND EISAI CO LTD1
Top patents by PatentIndex Score
23 records- 0194US11083705B2Pharmaceutical composition for treating tumorEISAI R&D MAN CO LTD·Filed 2020·Granted Aug 10, 2021·3 cites·17 claims
- 0293US6787534B2Sulfonamide-containing heterocyclic compoundsEISAI CO LTD·Filed 2000·Granted Sep 7, 2004·82 cites·9 claims
- 0380US6469043B1Sulfonamide-containing indole compoundsEISAI CO LTD·Filed 2000·Granted Oct 22, 2002·13 cites·22 claims
- 0476US8772269B2Use of sulfonamide-including compounds in combination with angiogenesis inhibitorsOWA TAKASHI·Filed 2005·Granted Jul 8, 2014·2 cites·6 claims
- 0575US2023212679A1Method for Predicting Effectiveness of Angiogenesis InhibitorEISAI R&D MAN CO LTD·Filed 2022·Application pending·0 cites
- 0670US6673787B2Sulfonamide-containing indole compoundsEISAI CO LTD·Filed 2002·Granted Jan 6, 2004·4 cites·19 claims
- 0768US6638964B2Sulfonamide-containing indole compoundsEISAI CO LTD·Filed 2002·Granted Oct 28, 2003·3 cites·9 claims
- 0867US12036204B2Pharmaceutical composition for treating tumorEISAI R&D MAN CO LTD·Filed 2021·Granted Jul 16, 2024·0 cites·18 claims
- 0967US2020199689A1Method for Predicting Effectiveness of Angiogenesis InhibitorEISAI R&D MAN CO LTD·Filed 2020·Application pending·0 cites
- 1062US2017191137A1Method For Predicting Effectiveness Of Angiogenesis InhibitorEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
- 1162US2021177802A1Pharmaceutical composition for treating tumorEISAI R&D MAN CO LTD·Filed 2021·Application pending·0 cites
- 1257US2009269352A1Antitumor agent comprising sulfonamide-containing heterocyclic compound combined with an angiogenesis inhibitorWAKABAYASHI TOSHIAKI·Filed 2009·Application pending·0 cites
- 1355US7834049B2Integrin expression inhibitorEISAI R&D MAN CO LTD·Filed 2005·Granted Nov 16, 2010·0 cites·4 claims
- 1453US2014148483A1Method For Predicting Effectiveness Of Angiogenesis InhibitorEISAI R&D MAN CO LTD·Filed 2012·Application pending·0 cites
- 1552US2009047365A1Novel Concomitant Use of Sulfonamide Compound with Anti-Cancer AgentEISAI R&D MAN CO LTD·Filed 2006·Application pending·0 cites
- 1652US2008286282A1Novel Use of Sulfonamide Compound in Combination with Angiogenesis InhibitorEISAI R&D MAN CO LTD·Filed 2006·Application pending·0 cites
- 1747US2005119303A1Antitumor agent comprising combination of sulfonamide-containing heterocyclic compound with an angiogenesis inhibitorEISAI CO LTD·Filed 2003·Application pending·0 cites
- 1847US2010267754A1Integrin expression inhibitorWAKABAYASHI TOSHIAKI·Filed 2010·Application pending·0 cites
- 1946US2004018192A1Integrin expression inhibitorsFiled 2001·Application pending·0 cites
- 2044US2010105031A1Method for prediction of the efficacy of vascularization inhibitorESAI R & D MAN CO LTD·Filed 2006·Application pending·0 cites
- 2144US2010291592A1Novel marker for sensitivity against sulfonamide compoundSEMBA TARO·Filed 2007·Application pending·0 cites
- 2242US2009047278A1Novel Combinational Use of Sulfonamide CompoundEISAI R&D MAN CO LTD·Filed 2006·Application pending·0 cites
- 2324US6645996B1Physiologically active substancesMERCIAN CORP AND EISAI CO LTD·Filed 1999·Granted Nov 11, 2003·1 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →